Aggressive Pain Management vs. Opioid Stewardship and Diversion Risk

Business Context

Effective pain management is a legitimate and important clinical priority, closely tied to patient satisfaction, recovery, and the ethical obligation to relieve suffering. However, opioid analgesics, among the most effective tools for managing moderate to severe pain, carry significant risks of dependence, diversion, and, in the context of a broader public health crisis in many regions, contribution to opioid misuse well beyond the treated patient. Aggressive, undifferentiated opioid prescribing to satisfy pain management and patient satisfaction goals can conflict directly with responsible stewardship of a genuinely high-risk medication class.

Healthcare TRIZ Resolution

Rather than uniformly restricting opioid prescribing, which risks undertreating genuine pain, or uniformly prioritizing aggressive pain control without stewardship safeguards, the resolution implements multimodal pain management as the default approach, combining non-opioid analgesics, regional anesthesia techniques where appropriate, and non-pharmacologic interventions to reduce overall opioid requirement, reserving opioid analgesia for the pain intensity and clinical context where it provides genuine incremental benefit, supported by structured risk screening for diversion and misuse risk that informs, but does not automatically deny, opioid prescribing decisions.

Applicable TRIZ Principles

Principle 40 – Composite Materials Combine multiple complementary pain management modalities, pharmacologic and non-pharmacologic, rather than relying on a single dominant intervention.

Principle 3 – Local Quality Match opioid use specifically to the pain intensity and clinical context where it provides genuine incremental benefit, rather than uniform application.

Principle 25 – Self-Service Use structured, standardized risk screening to inform, rather than dictate, individualized prescribing decisions.

Expected Outcome

Adequate pain control maintained

Reduced total opioid exposure

Lower diversion and misuse risk

Improved patient satisfaction consistency

Decision Indicators

Early indicators that this contradiction is limiting organizational performance include:

Opioid prescribing volume significantly above or below regional and specialty benchmarks without clear clinical explanation

No standardized multimodal pain management protocol in routine use for common procedures and conditions

Patient satisfaction scores related to pain management declining alongside opioid stewardship initiatives, suggesting stewardship is being implemented without adequate alternative pain control

No structured risk screening process informing opioid prescribing decisions

Clinicians reporting they feel caught between patient satisfaction pressure and stewardship guidance without adequate tools to reconcile the two

Monitoring these indicators helps pain management and pharmacy leadership ensure stewardship efforts do not inadvertently undertreat legitimate pain.